Bactiguard Holding AB

The company's capital structure shows a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Despite a negative return on equity of -2.49% and a return on assets of -1.44%, the company maintains a current ratio of 1.67, suggesting it has sufficient short-term assets to cover its liabilities. The liquidity position is assessed as medium, with free cash flow of 33,513,000 SEK and cash and equivalents of 44,261,000 SEK, but net cash is negative after subtracting total debt.

Profitability metrics show a significant decline, with a net loss of 7,844,000 SEK and an operating loss of 3,322,000 SEK. Gross profit of 133,058,000 SEK is a positive indicator, but it is not sufficient to offset the operating and net losses. The company's return on equity and return on assets are below the industry median, indicating underperformance in generating returns from equity and assets.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This concentration increases the risk associated with market-specific downturns or regulatory changes. The lack of segmental or geographic diversification data limits the ability to assess the company's exposure to different markets and potential growth opportunities.

The company's growth trajectory is uncertain, with a net loss and negative operating income reported in the latest financial period. Analyst estimates suggest a mean revenue of 216,000,000 SEK, slightly below the actual revenue of 228,800,000 SEK, indicating a potential decline in revenue. The mean EPS estimate is -0.64 SEK, which is worse than the last actual EPS of -0.22 SEK, suggesting a continued decline in profitability.

The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding. The company's capital expenditure of -5,720,000 SEK indicates a reduction in investment, which may affect long-term growth.

Recent events and filings do not provide specific details on new product launches, regulatory changes, or strategic initiatives. The company's financial performance and analyst estimates suggest a challenging outlook, with continued losses and a potential decline in revenue. The lack of detailed information on recent events limits the ability to assess the company's strategic direction and market position.